Gala Health vs MEDVi

Recorded prices, access and terms.

Decision table

The entries below are recorded provider statements unless a regulatory source is linked. A provider webpage does not independently verify its licenses or quality. Gala Health source · MEDVi source.

CompareGala HealthMEDVi
Recorded medication/program subtotalMonthly-plan rate unconfirmed. Advertised headline prices may require prepayment, a specific dose or introductory terms. Full required cost is unconfirmed.Recorded medication and program subtotal — semaglutide: $299/month. Other required fees, labs, dose changes and renewal terms: unconfirmed. This is not a verified all-in treatment cost.
Full required monthly costUnconfirmed: consultation, labs, membership, dose changes and shipping must be checkedUnconfirmed: consultation, labs, membership, dose changes and shipping must be checked
Drug type listedCompoundedBrand-name and compounded
ConsultationIncluded in the record; current conditions unconfirmedIncluded in the record; current conditions unconfirmed
Pharmacy licenseNot independently verified. Obtain the dispensing pharmacy name and verify its state license.Not independently verified. Obtain the dispensing pharmacy name and verify its state license.
Reported states50; confirm eligibility and clinician licensing in your state49; confirm eligibility and clinician licensing in your state
CancellationCancellation reported; notice, minimum term and refund conditions unconfirmedCancellation reported; notice, minimum term and refund conditions unconfirmed
Clinician/support as reportedLicensed providers, personalized treatment plansLicensed physicians, unlimited visits, 24/7 messaging
Recorded provider checkNo date recorded2026-09-26

Which should you choose?

Ask each provider for the full cost at your prescribed dose, required labs and visits, the dispensing pharmacy, the clinician's state license, renewal charges and written refund terms. Compare those answers with your clinician.

Compounded drugs are not FDA-approved and do not undergo FDA review for safety, effectiveness or quality before marketing. FDA source and recommendations.

Gala Health: evidence and terms

Read Gala Health's sourced record · Gala Health source

Visit Gala Health

MEDVi: evidence and terms

Recorded FDA letter (2026-02-20): FDA found claims on medvi.io for compounded GLP-1 products false or misleading, making the products misbranded under FD&C Act sections 502(a) and 502(bb). FDA letter.

Read MEDVi's sourced record · MEDVi source

Visit MEDVi

Compare the full provider directory · Compare recorded price subtotals

Compare providersVisit Embody →